Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain

References

• GaskinDJRichardPThe economic costs of pain in the United StatesJ Pain201213871572422607834
   PubMed Web of Science ®Google Scholar
• National Heart Lung, and Blood InstituteNHLBI Factbook, Fiscal Year 2012BethesdaNational Institutes of Health2013
   Google Scholar
• DeyoRAMirzaSKMartinBIBack pain prevalence and visit rates: estimates from US national surveys, 2002Spine200631232724272717077742
   PubMed Web of Science ®Google Scholar
• JohannesCBLeTKZhouXJohnstonJADworkinRHThe prevalence of chronic pain in United States adults: results of an internet-based surveyJ Pain201011111230123920797916
   PubMed Web of Science ®Google Scholar
• McCarbergBHNicholsonBDToddKHPalmerTPenlesLThe impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet surveyAm J Ther200815431232018645331
   PubMed Web of Science ®Google Scholar
• DominickKLAhernFMGoldCHHellerDAHealth-related quality of life among older adults with arthritisHealth Qual Life Outcomes20042514720300
   PubMedGoogle Scholar
• SalaffiFCarottiMStancatiAGrassiWHealth-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controlsAging Clin Exp Res200517425526316285189
   PubMed Web of Science ®Google Scholar
• TrescotAMHelmSHansenHOpioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) GuidelinesPain Physician2008112 SupplS5S6218443640
   PubMed Web of Science ®Google Scholar
• TrescotAMBoswellMVAtluriSLOpioid guidelines in the management of chronic non-cancer painPain Physician20069113916700278
   PubMedGoogle Scholar
• ChouRFanciulloGJFinePGAmerican Pain Society-American Academy of Pain Medicine Opioids Guidelines PanelClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• ChouRQaseemASnowVClinical Efficacy Assessment Subcommittee of the American College of PhysiciansAmerican College of PhysiciansAmerican Pain Society Low Back Pain Guidelines PanelDiagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain SocietyAnn Intern Med2007147747849117909209
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• ArgoffCESilversheinDIA comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needsMayo Clin Proc200984760261219567714
   PubMed Web of Science ®Google Scholar
• WaldenMNichollsFASmithKJTuckerGTThe effect of ethanol on the release of opioids from oral prolonged-release preparationsDrug Dev Ind Pharm200733101101111117882730
   PubMed Web of Science ®Google Scholar
• US Food Drug AdministrationGuidance for Industry. Abuse-deterrent opioids – evaluation and labeling2013 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM334743.pdfAccessed November 21, 2013
   Google Scholar
• The American Society of Health-System PharmacistsHydrocodone2011 Available from: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601006.htmlAccessed: February 24, 2015
   Google Scholar
• Co-Gesic – hydrocodone bitartrate and acetaminophen tablet [package insert]Smyrna, GAUCB, Inc.2011
   Google Scholar
• BarkinRLAcetaminophen, aspirin, or ibuprofen in combination analgesic productsAm J Ther20018643344211704782
   PubMedGoogle Scholar
• Vicodin^® (hydrocodone bitartrate and acetaminophen tablets, USP) 5 mg/500 mg [package insert]North Chicago, ILAbbVie Inc.2014
   Google Scholar
• US Food and Drug AdministrationPrescription drug products containing acetaminophen; actions to reduce liver injury from unintentional overdoseFed Register2011761026912697
   Google Scholar
• BowerWAJohnsMMargolisHSWilliamsITBellBPPopulation-based surveillance for acute liver failureAm J Gastroenterol2007102112459246317608778
   PubMed Web of Science ®Google Scholar
• American Pain SocietyNational Pharmaceutical CounselPain: Current Understanding of Assessment, Management, and Treatment. Section III: Types of treatments2012 Available from: http://pain-topics.org/pdf/Pain_APS_2006.pdfAccessed July 2, 2013
   Google Scholar
• CIMA LABS IncOraGuard™: tamper-deterrent, alcohol-resistant extended release technology2012 Available from: http://www.cimalabs.com/technology/oraguardAccessed January 12, 2015
   Google Scholar
• DarwishMYangRTracewellWRobertsonPJrBondMSingle- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteersClin Ther201537239040125542074
   PubMed Web of Science ®Google Scholar
• DarwishMYangRTracewellWRobertsonPBondMDose proportionality of a hydrocodone extended-release tablet formulated with abuse-deterrence technologyClin Drug Investig2015355291297
   Web of Science ®Google Scholar
• International Conference on Harmonisation Working GroupICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1)International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human UseJune 10, 1996Washington DC Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdfAccessed March 1, 2011
   Google Scholar
• GuyWECDEU Assessment Manual for Psychopharmacology (Revised)Washington, DCNational Institute of Mental Health, US Department of Health, Education and Welfare1976
   Google Scholar
• CleelandCSRyanKMPain assessment: global use of the brief pain inventoryAnn Acad Med Singapore19942321291388080219
   PubMedGoogle Scholar
• WareJEJrKosinskiMBaylissMSMcHorneyCARogersWHRaczekAComparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes StudyMed Care1995334 SupplAS264AS2797723455
   PubMed Web of Science ®Google Scholar
• WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
   PubMed Web of Science ®Google Scholar
• HandelsmanLCochraneKJAronsonMJNessRRubinsteinKJKanofPDTwo new rating scales for opiate withdrawalAm J Drug Alcohol Abuse19871332933083687892
   PubMed Web of Science ®Google Scholar
• WessonDRLingWThe clinical opiate withdrawal scale (COWS)J Psychoactive Drugs200335225325912924748
   PubMed Web of Science ®Google Scholar
• ButlerSFFernandezKBenoitCBudmanSHJamisonRNValidation of the revised screener and opioid assessment for patients with pain (SOAPP-R)J Pain20089436037218203666
   PubMed Web of Science ®Google Scholar
• WuSMComptonPBolusRThe Addiction Behaviors Checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic painJ Pain Symptom Manage200632434235117000351
   PubMed Web of Science ®Google Scholar
• ButlerSFBudmanSHFernandezKCDevelopment and validation of the current opioid misuse measurePain20071301–214415617493754
   PubMed Web of Science ®Google Scholar
• DworkinRHTurkDCPeirce-SandnerSResearch design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsPain2010149217719320207481
   PubMed Web of Science ®Google Scholar
• VojtassakJVojtassakJJacobsARynnLWaechterSRicharzUA phase IIIb, multicentre, randomised, parallel-group, placebo-controlled, double-blind study to investigate the efficacy and safety of OROS hydromorphone in subjects with moderate-to-severe chronic pain induced by osteoarthritis of the hip or the kneePain Res Treat2011201123950122110921
   PubMedGoogle Scholar
• VinikAITuchmanMSafirsteinBLamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studiesPain20071281–216917917161535
   PubMed Web of Science ®Google Scholar
• BeydounAShaibaniAHopwoodMWanYOxcarbazepine in painful diabetic neuropathy: results of a dose-ranging studyActa Neurol Scand2006113639540416674606
   PubMed Web of Science ®Google Scholar
• KatzNRauckRAhdiehHA 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back painCurr Med Res Opin200723111712817257473
   PubMed Web of Science ®Google Scholar
• HaleMEAhdiehHMaTRauckREfficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled studyJ Pain20078217518417145204
   PubMed Web of Science ®Google Scholar
• Opana ER [package insert]Chadds Ford, PAEndo Pharmaceuticals Inc.2013
   Google Scholar
• Oxycontin [package insert]Stamford, CTPurdue Pharma LP2013
   Google Scholar
• RothSHFleischmannRMBurchFXAround-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluationArch Intern Med2000160685386010737286
   PubMedGoogle Scholar
• PalangioMMorrisEDoyleRTJrDornseifBEValenteTJCombination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back painClin Ther2002241879911833838
   PubMed Web of Science ®Google Scholar
• BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician2008112 SupplS105S12018443635
   PubMed Web of Science ®Google Scholar
• NobleMTregearSJTreadwellJRSchoellesKLong-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safetyJ Pain Symptom Manage200835221422818178367
   PubMed Web of Science ®Google Scholar
• MartellBAO’ConnorPGKernsRDSystematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addictionAnn Intern Med2007146211612717227935
   PubMed Web of Science ®Google Scholar
• AmabileCMBowmanBJOverview of oral modified-release opioid products for the management of chronic painAnn Pharmacother2006407–81327133516868222
   PubMed Web of Science ®Google Scholar
• CramerMPSaksSRTranslating safety, efficacy and compliance into economic value for controlled release dosage formsPharmacoeconomics19945648250410150160
   PubMed Web of Science ®Google Scholar
• GreenbergRNOverview of patient compliance with medication dosing: a literature reviewClin Ther1984655925996383611
   PubMed Web of Science ®Google Scholar